TABLE II.
Recurrences and Complications Associated With the Treatments for Oral and Plunging Ranulas (n = 864).
| Sublingual Gland Excision |
OK-432* | Aspiration | Ranula Excision |
Marsupialization | Submandibular Gland Excision |
Submandibular Gland+Ranula |
Sublingual Gland+Ranula (Unspecified Incision) |
Sublingual Gland+Ranula (Transoral Incision) |
Sublingual Gland+Ranula (Cervical Incision) |
Sublingual+ Submandibular Glands + Ranula |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Recurrences | 3/299 (1.0%) | 39/79 (49.4%) | 9/11 (81.8%) | 16/36 (44.4%) | 23/95 (24.2%) | 0/1 (0%) | 1/3 (33.3%) | 3/139 (2.2%) | 0/170 (0%) | 0/16 (0%) | 2/15 (13.3%) |
| Complications | |||||||||||
| Tongue hypesthesia | 6/299 (2.0%) | 0/79 (0%) | 0/11 (0%) | 3/36 (8.3%) | 0/95 (0%) | 0/1 (0%) | 1*/3 (33.3%) | 15/139 (10.8%) | 7/170 (4.1%) | 4/16 (25%) | 3/15 (20%) |
| Wharton duct injury | 0/299 (0%) | 0/79 (0%) | 0/11 (0%) | 0/36 (0%) | 0/95 (0%) | 0/1 (0%) | 0/3 (0%) | 0/139 (0%) | 1/170 (0.6%) | 0/16 (0%) | 0/15 (0%) |
| Bleeding/hematoma | 0/299 (0%) | 0/79 (0%) | 0/11 (0%) | 0/36 (0%) | 0/95 (0%) | 0/1 (0%) | 0/3 (0%) | 0/139 (0%) | 8/170 (4.7%) | 2/16 (12.5%) | 0/15 (0%) |
| Post-op infection | 0/299 (0%) | 0/79 (0%) | 0/11 (0%) | 1/36 (2.8%) | 0/95 (0%) | 0/1 (0%) | 0/3 (0%) | 0/139 (0%) | 4/170 (2.4%) | 0/16 (0%) | 0/15 (0%) |
| Total | 9/299 (3.01%) | 39/79 (49.4%) | 9/11 (81.8%) | 20/36 (55.6%) | 23/95 (24.2%) | 0/1 (0%) | 2/3 (66.7%) | 18/139 (12.9%) | 20/170 (11.8%) | 6/16 (37.5%) | 5/15 (33.3%) |
| Ranula total | 299 | 79 | 11 | 36 | 95 | 1 | 3 | 139 | 170 | 16 | 15 |
| Oral total | 0 | 40 | 11 | 5 | 86 | 0 | 0 | 9 | 146 | 0 | 0 |
| Plunging total | 13 | 39 | 0 | 5 | 0 | 1 | 3 | 1 | 24 | 16 | 15 |
| Zhao study | 286 | 26 | 9 | 129 | |||||||
| Sublingual Gland Excision Ref. 4, 8, 11 | OK-432* Ref. 15, 16, 17 | Aspiration Ref. 18 | Ranula Excision Ref. 4, 6, 26 | Marsupialization Ref. 3, 4, 19, 20, 21, 22 | Submandibular Gland Excision | Submandibular Gland+Ranula | Sublingual Gland+Ranula (Unspecified Incision) Ref. 4, 19 | Sublingual Gland+Ranula (Transoral Incision) Ref. 3, 4, 10, 11, 12, 20, 22, 26 | Sublingual Gland+Ranula (Cervical Incision) Ref. 3, 6, 7, 26 | Sublingual+ Submandibular Glands + Ranula Ref. 26 | |
|
| |||||||||||
| Sample sizes of studies that were combined to get total | 2, 11, 286 | 21, 26, 32 | 11 | 2, 3, 5,†, 26 | 6, 7, 7, 9, 10, 56 | 1 | 3,† | 10, 129 | 1, 2, 3, 4, 6, 6,†, 13, 67, 68 | 1, 2, 2,†, 5, 6 | 2,†, 13 |
Post-op = postoperative; Ref. = references from which case series were extracted.
**
Rate based on initial injection; number of injections ranged from 1 to 5, with an average of 1.8 injections per person.
†
Taken from the University of North Carolina series.